From the Infectious Diseases Society of America (IDSA) meeting - important new findings in HIV treatment and pathogenesis, 2003

Hopkins HIV Rep. 2004 Jan;16(1):2-3.
No abstract available

Publication types

  • Congress
  • Newspaper Article

MeSH terms

  • Antiretroviral Therapy, Highly Active / adverse effects
  • Biomarkers
  • Drug Therapy, Combination
  • Female
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • HIV Infections / transmission
  • HIV Protease Inhibitors / administration & dosage
  • HIV Protease Inhibitors / adverse effects
  • HIV Protease Inhibitors / therapeutic use*
  • Humans
  • Infectious Disease Transmission, Vertical / prevention & control
  • Pregnancy
  • Pregnancy Complications, Infectious / prevention & control
  • Reverse Transcriptase Inhibitors / administration & dosage
  • Reverse Transcriptase Inhibitors / adverse effects
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • United States

Substances

  • Biomarkers
  • HIV Protease Inhibitors
  • Reverse Transcriptase Inhibitors